The Impact of Lymphodepletion on Myeloid-Derived Suppressor Cells and Other Immune Modulators in Patients Receiving Chimeric Antigen Receptor (CAR) T-cell Therapy: A Clinical Pilot Study.
Principal Investigator
Study Number
STUDY02001589
Available at the following location(s)
- Lebanon
Do you need help with some of the labels on this page?
Read our glossary of terms